Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
about
The evolution of poxvirus vaccinesDevelopment of eczema vaccinatum in atopic mouse models and efficacy of MVA vaccination against lethal poxviral infectionIdentification of the feline humoral immune response to Bartonella henselae infection by protein microarrayIdentification of a common immune signature in murine and human systemic Salmonellosis.Expanding the repertoire of Modified Vaccinia Ankara-based vaccine vectors via genetic complementation strategiesThe immunology of smallpox vaccines.Defining the humoral immune response to infectious agents using high-density protein microarrays.Novel Nonreplicating Vaccinia Virus Vector Enhances Expression of Heterologous Genes and Suppresses Synthesis of Endogenous Viral ProteinsA prospective analysis of the Ab response to Plasmodium falciparum before and after a malaria season by protein microarrayEvaluation of smallpox vaccines using variola neutralization.Genome-wide profiling of humoral immune response to Coxiella burnetii infection by protein microarray.Whole genome identification of C. trachomatis immunodominant antigens after genital tract infections and effect of antibiotic treatment of pigtailed macaques.A broadly applicable approach to T cell epitope identification: application to improving tumor associated epitopes and identifying epitopes in complex pathogens.GM-CSF production allows the identification of immunoprevalent antigens recognized by human CD4+ T cells following smallpox vaccination.High-throughput profiling of the humoral immune responses against thirteen human papillomavirus types by proteome microarrays.The neutralizing antibody response to the vaccinia virus A28 protein is specifically enhanced by its association with the H2 proteinRapid identification of monospecific monoclonal antibodies using a human proteome microarray.The impact of "omic" and imaging technologies on assessing the host immune response to biodefence agents.The identification of HLA class II-restricted T cell epitopes to vaccinia virus membrane proteins.Immunosignatures can predict vaccine efficacy.Plasmodium immunomics.Profiling humoral immune responses to P. falciparum infection with protein microarraysHuman immune responses to Burkholderia pseudomallei characterized by protein microarray analysis.Inferring epitopes of a polymorphic antigen amidst broadly cross-reactive antibodies using protein microarrays: a study of OspC proteins of Borrelia burgdorferiProtein microarrays and biomarkers of infectious diseaseEnhancement of immune response to an antigen delivered by vaccinia virus by displaying the antigen on the surface of intracellular mature virion.Establishment of the black-tailed prairie dog (Cynomys ludovicianus) as a novel animal model for comparing smallpox vaccines administered preexposure in both high- and low-dose monkeypox virus challenges.Applications of protein microarrays for biomarker discovery.T cell antigen discovery using soluble vaccinia proteome reveals recognition of antigens with both virion and nonvirion association.The stability and complexity of antibody responses to the major surface antigen of Plasmodium falciparum are associated with age in a malaria endemic areaMeasurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsFailure of the smallpox vaccine to develop a skin lesion in vaccinia virus-naïve individuals is related to differences in antibody profiles before vaccination, not after.Immunodominant "asymptomatic" herpes simplex virus 1 and 2 protein antigens identified by probing whole-ORFome microarrays with serum antibodies from seropositive asymptomatic versus symptomatic individualsUncovering the interplay between CD8, CD4 and antibody responses to complex pathogens.Characterization of monoclonal antibody's binding kinetics using oblique-incidence reflectivity difference approachMultidimensional glycan arrays for enhanced antibody profilingA systems biology approach for diagnostic and vaccine antigen discovery in tropical infectious diseasesDeletion of specific immune-modulatory genes from modified vaccinia virus Ankara-based HIV vaccines engenders improved immunogenicity in rhesus macaques.Large screen approaches to identify novel malaria vaccine candidates.Humoral immunity to smallpox vaccines and monkeypox virus challenge: proteomic assessment and clinical correlations.
P2860
Q26995905-D0CB839F-7A69-4F83-B679-DAD430D90AA6Q27321985-51CB320A-9797-4F81-8AD8-792D19113CADQ28750496-ADED7E11-2ABD-4AA1-8742-14CEB150A0B1Q30424877-47D6E2C0-5142-42E0-AF35-BF94D987F837Q33440600-AD7CA1DE-0002-4676-B649-0817292C2D25Q33679943-D5B31E0F-468D-4FD7-8068-EDF1B90C084DQ33738002-893D2534-F9D4-4BD1-8D93-D26E43741606Q33770634-1C23F699-9EB5-4280-A788-5D8CC137F5FCQ33859633-5E27C4C1-F8AF-4DA7-9E7D-FD91F43C7806Q33920540-730FDCAE-1551-44D2-A887-0C8ED4F1A0F5Q33943702-7DCCEC66-E531-4922-913B-750F3BAF460CQ33957971-3A99C1F9-D4B8-4889-992E-0CB12BA10FE7Q34004266-56892C54-5901-4017-8B04-BA86C6E59997Q34023265-2DAA7988-6475-43A5-8F4C-674B8689E46CQ34037232-61DA5E3F-DA99-41CB-960D-AC3607769160Q34039477-EBF6B611-9A85-4F37-905E-5F11963AC8CDQ34151218-1A9B6939-D350-4C00-A60E-41FB1E364F00Q34275632-3280D5AC-6AA7-4C62-B8CD-BB702BEB8EB9Q34288498-226583B1-7F2B-48D3-885D-B2F22B3E34C4Q34380788-A9FC7173-FE96-4487-97C7-9D8382C8FF6FQ34419934-92441539-4D32-4B28-932C-EE682CBE7BCDQ34495128-B96B57C5-3820-407F-B8B7-03A8147F2321Q34743375-54CD5116-D262-4F45-9E91-3F401B4E4675Q34797227-98B3C19B-8E2B-4B5A-8CC7-CCCDF3137CADQ35002206-2055B240-8B1C-4491-BF9E-3E541F41EB23Q35113336-4874E5C8-88A7-4DC6-BCDE-DFC5B9E1982EQ35140284-CF2B0AE4-EA07-4A18-9433-BCD5F074E7BFQ35170387-C029CA57-E1D7-47F8-8B90-A3E80A86D8B6Q35206861-BEDF779E-1A99-45F1-A82B-EA23E1BE65BDQ35579613-3959C170-AB25-40CD-9C7F-8B054F0ABC7DQ35634159-14D946E6-9940-4F5A-A7CC-A6DAAB871086Q35805278-CED582E5-F290-40FE-BE5B-1524798B2EC5Q35868029-8A8E174B-3C81-456A-B37B-FBB9FF0E80E1Q35998125-7E4D0A1D-DF74-4F99-8299-692E0CE6953AQ36211543-BF12D896-FBBD-415D-AAB8-ACDA3C954930Q36291980-FAC23808-265E-48EA-A58E-B052D3933E23Q36338404-1AB24B27-DC13-4812-AEEE-E6CB324F5599Q36397581-7BDD13E7-DEE9-465C-83D5-96877F15B2F7Q36510147-74DA2007-248E-4704-A472-A06302D25DECQ36559636-B633B478-D1EE-48EA-8CE9-4105E755D563
P2860
Antibody profiling by proteome microarray reveals the immunogenicity of the attenuated smallpox vaccine modified vaccinia virus ankara is comparable to that of Dryvax.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Antibody profiling by proteome ...... comparable to that of Dryvax.
@ast
Antibody profiling by proteome ...... comparable to that of Dryvax.
@en
type
label
Antibody profiling by proteome ...... comparable to that of Dryvax.
@ast
Antibody profiling by proteome ...... comparable to that of Dryvax.
@en
prefLabel
Antibody profiling by proteome ...... comparable to that of Dryvax.
@ast
Antibody profiling by proteome ...... comparable to that of Dryvax.
@en
P2093
P2860
P921
P356
P1433
P1476
Antibody profiling by proteome ...... comparable to that of Dryvax.
@en
P2093
D Huw Davies
Douglas M Molina
Frances K Newman
Jenny E Hernandez
Linda S Wyatt
Patricia L Earl
Philip L Felgner
Sharon E Frey
Siddiqua Hirst
Sookhee Chun
P2860
P304
P356
10.1128/JVI.01706-07
P407
P50
P577
2007-10-31T00:00:00Z